ATM, ATR and TP53 are tumour suppressors and key mediators of the DNA damage response (DDR) and therefore, mutation or loss of function of these specific targets may lead to genomic instability that can in turn can accelerate drug resistance. Here, TP53 is linked to neoplasm.